Co-Authors
This is a "connection" page, showing publications co-authored by ADEL K EL-NAGGAR and ANN MARIE GILLENWATER.
Connection Strength
2.178
-
Proliferative verrucous leukoplakia: recognition and differentiation from conventional leukoplakia and mimics. Head Neck. 2014 Nov; 36(11):1662-8.
Score: 0.492
-
Primary intestinal-like adenocarcinoma of major salivary glands: 2 instances of previously undocumented phenotype. Head Neck. 2013 Aug; 35(8):E234-6.
Score: 0.433
-
Moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the larynx: a clinically aggressive tumor. Laryngoscope. 2005 Jul; 115(7):1191-5.
Score: 0.261
-
Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity! Adv Anat Pathol. 2013 Nov; 20(6):416-23.
Score: 0.116
-
Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy. Cancer. 2009 Apr 15; 115(8):1669-79.
Score: 0.085
-
Concurrent epithelioid malignant peripheral nerve sheath tumor and papillary thyroid carcinoma in the treated field of Hodgkin's disease. Head Neck. 2008 May; 30(5):675-9.
Score: 0.079
-
Understanding the biological basis of autofluorescence imaging for oral cancer detection: high-resolution fluorescence microscopy in viable tissue. Clin Cancer Res. 2008 Apr 15; 14(8):2396-404.
Score: 0.079
-
Multispectral optical imaging device for in vivo detection of oral neoplasia. J Biomed Opt. 2008 Mar-Apr; 13(2):024019.
Score: 0.078
-
Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Int J Oncol. 2003 Feb; 22(2):409-14.
Score: 0.055
-
Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort. Cancer. 2023 03 01; 129(5):714-727.
Score: 0.055
-
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol. 2016 Feb; 2(2):209-16.
Score: 0.034
-
The future of medical diagnostics: review paper. Head Neck Oncol. 2011 Aug 23; 3:38.
Score: 0.025
-
At the frontiers of surgery: review. Head Neck Oncol. 2011 Feb 09; 3(1):7.
Score: 0.024
-
Comparison of multispectral wide-field optical imaging modalities to maximize image contrast for objective discrimination of oral neoplasia. J Biomed Opt. 2010 Nov-Dec; 15(6):066017.
Score: 0.024
-
Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial. Ann Intern Med. 2010 Sep 21; 153(6):358-67.
Score: 0.023
-
Emerging roles for multimodal optical imaging in early cancer detection: a global challenge. Technol Cancer Res Treat. 2010 Apr; 9(2):211-7.
Score: 0.023
-
Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res. 2010 Jan 15; 16(2):764-74.
Score: 0.022
-
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res (Phila). 2009 Nov; 2(11):931-41.
Score: 0.022
-
Head & neck optical diagnostics: vision of the future of surgery. Head Neck Oncol. 2009 Jul 13; 1:25.
Score: 0.022
-
Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose. Int J Cancer. 2009 Jun 01; 124(11):2634-42.
Score: 0.021
-
Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia. Neoplasia. 2009 Jun; 11(6):542-51.
Score: 0.021
-
Objective detection and delineation of oral neoplasia using autofluorescence imaging. Cancer Prev Res (Phila). 2009 May; 2(5):423-31.
Score: 0.021
-
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol. 2009 Apr 20; 27(12):1976-82.
Score: 0.021
-
Cyclin D1 and cancer development in laryngeal premalignancy patients. Cancer Prev Res (Phila). 2009 Jan; 2(1):14-21.
Score: 0.021
-
Monte Carlo model to describe depth selective fluorescence spectra of epithelial tissue: applications for diagnosis of oral precancer. J Biomed Opt. 2008 Nov-Dec; 13(6):064012.
Score: 0.021
-
In vivo imaging of oral neoplasia using a miniaturized fiber optic confocal reflectance microscope. Oral Oncol. 2008 Nov; 44(11):1059-66.
Score: 0.020
-
Confocal microscopy and molecular-specific optical contrast agents for the detection of oral neoplasia. Technol Cancer Res Treat. 2007 Oct; 6(5):361-74.
Score: 0.019
-
Real-time detection of epidermal growth factor receptor expression in fresh oral cavity biopsies using a molecular-specific contrast agent. Int J Cancer. 2006 Jun 15; 118(12):3062-71.
Score: 0.017
-
Vision enhancement system for detection of oral cavity neoplasia based on autofluorescence. Head Neck. 2004 Mar; 26(3):205-15.
Score: 0.015
-
A far-red fluorescent contrast agent to image epidermal growth factor receptor expression. Photochem Photobiol. 2004 Mar; 79(3):272-9.
Score: 0.015
-
Confocal microscopy for real-time detection of oral cavity neoplasia. Clin Cancer Res. 2003 Oct 15; 9(13):4714-21.
Score: 0.014